Added to YB: 2025-12-22
Pitch date: 2025-12-18
VIRP.PA [bullish]
Virbac SA
+1.01%
current return
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Company Info
Virbac SA manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, and the Pacific.
Market Cap
EUR 2.9B
Pitch Price
EUR 346.00
Price Target
N/A
Dividend
0.42%
EV/EBITDA
11.21
P/E
21.82
EV/Sales
2.16
Sector
Pharmaceuticals
Category
growth
Virbac (VIRP France): a targeted bolt-on adds a durable chronic care pillar
VIRP.PA (update): Acquired Thyronom feline hyperthyroidism treatment rights for €114M. Product generates €27M globally, Virbac takes €14M from 2026. Chronic condition affecting 10%+ older cats offers predictable recurring revenue vs episodic treatments. Accretive from year 1, leverages existing infrastructure with minimal fixed costs.
Read full article (2 min)